Skip to content
Politically.com Search all
Menu

2026 · 1st Quarter (Jan 1 - Mar 31)

TELIX PHARMACEUTICALS US

Filed by LIBERTY PARTNERS GROUP, LLC.

Open official filing
Source: Lobbying Disclosure APIRecently refreshed. 2026-08-03 06:26:15 UTC.

Source-reported fields

Filing overview

Type
1st Quarter - Report
Posted
Apr 17, 2026
Income
$50,000.00
Expenses
Not reported
Filing UUID
b1ecf2d6-648e-4a7c-a253-a0ec6ea1bd0b
Termination date
Not reported

Literal source text

Lobbying issues and bill citations

HCR · Health Issues

Medicare reimbursement, working with Congress on legislation relating to the early detection and treatment of deadly diseases.

MMM · Medicare/Medicaid

Medicare reimbursement, working with Congress on legislation relating to the early detection and treatment of deadly diseases.

MED · Medical/Disease Research/Clinical Labs

Medicare reimbursement, working with Congress on legislation relating to the early detection and treatment of deadly diseases.

Relationship and amount limits

Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.